The Miller Firm is currently pursuing product liability lawsuits against the manufacturers of morcellators for their failure to warn doctors and patients of the significant risk of cancer from the use of the devices during a hysterectomy or myomectomy.
In April 2014, the FDA issued this safety communication detailing the risks associated with power morcellators in procedures such as hysterectomys and myomectomys. In particular, the FDA warned,“If laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival. For this reason, and because there is no reliable method for predicting whether a woman with fibroids may have a uterine sarcoma, the FDA discourages the use of laparoscopic power morcellation during hysterectomy or myomectomy for uterine fibroids.”
If you have been diagnosed with uterine cancer following a hysterectomy or myomectomy where a power morcellator was used, you may be entitled to compensation. Please call us for a free case evaluation or message us below and we will respond to you shortly.